Skip to main content

certociclib

Generic: Certociclib

certociclib: 1 clinical trial tracked.

certociclib evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about certociclib, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trial Registry Records (1)

A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients With Advanced Solid Tumors

NCT05252416Registry updated 2025-11-28·Phase 1·BPMC
Terminated

Primary endpoint: [Phase 1] Determine the maximum tolerated dose (MTD) of BLU-222

Interventionalopen50 targetStarted 2022-04Completion 2025-0723 sites · Italy, United Kingdom, United StatesBlueprint Medicines Corporation